Related Experiment Videos
Machine learning-based prediction models for postoperative pulmonary complications in elderly patients undergoing
Qiang Zhong1, Guiming Huang1, Wen Zhou1
1Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People's Hospital), Ganzhou, Jiangxi, China.
Frontiers in Surgery
|July 29, 2026
Summary
This study developed an interpretable XGBoost model to predict postoperative pulmonary complications (PPCs) in older adults undergoing abdominal surgery, showing improved risk stratification for better perioperative care.
Area of Science:
- Medical Informatics
- Surgical Oncology
- Geriatric Medicine
Background:
- Postoperative pulmonary complications (PPCs) are frequent in elderly patients after abdominal surgery.
- Existing risk prediction tools often lack generalizability and clinical interpretability for this demographic.
Purpose of the Study:
- To develop and validate a machine learning model for predicting PPCs in older adults undergoing abdominal surgery.
- To enhance the interpretability of risk prediction models for clinical decision-making.
Main Methods:
- Retrospective cohort study of 2,456 elderly patients (>=65 years) for model development and 542 for external validation.
- Comparison of six machine learning algorithms, including XGBoost, logistic regression, and neural networks.
- Evaluation using discrimination, calibration, decision curve analysis, and SHAP for interpretability.
Main Results:
- The XGBoost model demonstrated superior performance, achieving AUCs of 0.856 and 0.821 in independent and external validation cohorts, respectively.
- Key predictors identified by SHAP analysis included ASA physical status, COPD, and surgical site.
- The model effectively stratified patients into low (6.9%), moderate (24.4%), and high (37.6%) risk groups for PPCs.
Conclusions:
- An interpretable gradient-boosting model (XGBoost) shows promise for risk-stratified perioperative assessment in elderly surgical patients.
- Prospective multicenter validation is recommended prior to widespread clinical adoption.